Literature DB >> 28087531

Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.

Na Tian1, Lina Faller2, Daniel A Leffler3, Ciaran P Kelly3, Joshua Hansen3, Jos A Bosch4,5, Guoxian Wei1, Bruce J Paster2,6, Detlef Schuppan3,7, Eva J Helmerhorst8.   

Abstract

Celiac disease (CD) is a chronic immune-mediated enteropathy induced by dietary gluten in genetically predisposed individuals. Saliva harbors the second highest bacterial load of the gastrointestinal (GI) tract after the colon. We hypothesized that enzymes produced by oral bacteria may be involved in gluten processing in the intestine and susceptibility to celiac disease. The aim of this study was to investigate salivary enzymatic activities and oral microbial profiles in healthy subjects versus patients with classical and refractory CD. Stimulated whole saliva was collected from patients with CD in remission (n = 21) and refractory CD (RCD; n = 8) and was compared to healthy controls (HC; n = 20) and subjects with functional GI complaints (n = 12). Salivary gluten-degrading activities were monitored with the tripeptide substrate Z-Tyr-Pro-Gln-pNA and the α-gliadin-derived immunogenic 33-mer peptide. The oral microbiome was profiled by 16S rRNA-based MiSeq analysis. Salivary glutenase activities were higher in CD patients compared to controls, both before and after normalization for protein concentration or bacterial load. The oral microbiomes of CD and RCD patients showed significant differences from that of healthy subjects, e.g., higher salivary levels of lactobacilli (P < 0.05), which may partly explain the observed higher gluten-degrading activities. While the pathophysiological link between the oral and gut microbiomes in CD needs further exploration, the presented data suggest that oral microbe-derived enzyme activities are elevated in subjects with CD, which may impact gluten processing and the presentation of immunogenic gluten epitopes to the immune system in the small intestine.IMPORTANCE Ingested gluten proteins are the triggers of intestinal inflammation in celiac disease (CD). Certain immunogenic gluten domains are resistant to intestinal proteases but can be hydrolyzed by oral microbial enzymes. Very little is known about the endogenous proteolytic processing of gluten proteins in the oral cavity. Given that this occurs prior to gluten reaching the small intestine, such enzymes are likely to contribute to the composition of the gluten digest that ultimately reaches the small intestine and causes CD. We demonstrated that endogenous salivary protease activities are incomplete, likely liberating peptides from larger gluten proteins. The potentially responsible microbes were identified. The study included refractory CD patients, who have been studied less with regard to CD pathogenesis.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  16S rRNA; celiac disease; enzyme; microbiome; saliva

Mesh:

Substances:

Year:  2017        PMID: 28087531      PMCID: PMC5335528          DOI: 10.1128/AEM.03330-16

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  47 in total

1.  Salivary microbiota and metabolome associated with celiac disease.

Authors:  Ruggiero Francavilla; Danilo Ercolini; Maria Piccolo; Lucia Vannini; Sonya Siragusa; Francesca De Filippis; Ilaria De Pasquale; Raffaella Di Cagno; Michele Di Toma; Giorgia Gozzi; Diana I Serrazanetti; Maria De Angelis; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

2.  Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease?

Authors:  Na Tian; Irene Messana; Daniel A Leffler; Ciaran P Kelly; Joshua Hansen; Tiziana Cabras; Alfredo D'Alessandro; Detlef Schuppan; Massimo Castagnola; Eva J Helmerhorst
Journal:  Proteomics Clin Appl       Date:  2015-04-24       Impact factor: 3.494

3.  Enzyme therapy for management of coeliac disease.

Authors:  Hugh J Cornell; Finlay A Macrae; Joy Melny; Catherine J Pizzey; Fiona Cook; Sandra Mason; Prithi S Bhathal; Teodor Stelmasiak
Journal:  Scand J Gastroenterol       Date:  2005-11       Impact factor: 2.423

4.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

Review 5.  Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease.

Authors:  Tamara Matysiak-Budnik; Celine Candalh; Christophe Cellier; Christophe Dugave; Abdelkader Namane; Teresita Vidal-Martinez; Nadine Cerf-Bensussan; Martine Heyman
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

6.  Bacterial community variation in human body habitats across space and time.

Authors:  Elizabeth K Costello; Christian L Lauber; Micah Hamady; Noah Fierer; Jeffrey I Gordon; Rob Knight
Journal:  Science       Date:  2009-11-05       Impact factor: 47.728

7.  Oral health status and salivary properties in relation to gluten-free diet in children with celiac disease.

Authors:  Eyal Shteyer; Tamar Berson; Odelia Lachmanovitz; Ariela Hidas; Michael Wilschanski; Moti Menachem; Edna Shachar; Joseph Shapira; Doron Steinberg; Moti Moskovitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-07       Impact factor: 2.839

8.  Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.

Authors:  Eva J Helmerhorst; Maram Zamakhchari; Detlef Schuppan; Frank G Oppenheim
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

9.  Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization.

Authors:  Raffaella Di Cagno; Maria De Angelis; Ilaria De Pasquale; Maurice Ndagijimana; Pamela Vernocchi; Patrizia Ricciuti; Francesca Gagliardi; Luca Laghi; Carmine Crecchio; Maria Elisabetta Guerzoni; Marco Gobbetti; Ruggiero Francavilla
Journal:  BMC Microbiol       Date:  2011-10-04       Impact factor: 3.605

10.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

View more
  17 in total

1.  Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease.

Authors:  Karla A Bascuñán; Magdalena Araya; Leda Roncoroni; Luisa Doneda; Luca Elli
Journal:  Adv Nutr       Date:  2020-01-01       Impact factor: 8.701

2.  The association between coeliac disease and periodontitis: Results from NHANES 2009-2012.

Authors:  Thomas Spinell; Francesco DeMayo; Matthew Cato; Ashley Thai; Eva J Helmerhorst; Peter H R Green; Benjamin Lebwohl; Ryan T Demmer
Journal:  J Clin Periodontol       Date:  2018-01-11       Impact factor: 8.728

3.  Oral Manifestations in Pediatric Patients with Coeliac Disease - A Review Article.

Authors:  Viviana Marisa Pereira Macho; Ana Sofia Coelho; Diana Maria Veloso E Silva; David José Casimiro de Andrade
Journal:  Open Dent J       Date:  2017-10-24

Review 4.  Oral Health Impact Profile in Celiac Patients: Analysis of Recent Findings in a Literature Review.

Authors:  Gabriele Cervino; Luca Fiorillo; Luigi Laino; Alan Scott Herford; Floriana Lauritano; Giuseppe Lo Giudice; Fausto Famà; Rossella Santoro; Giuseppe Troiano; Gaetano Iannello; Marco Cicciù
Journal:  Gastroenterol Res Pract       Date:  2018-10-24       Impact factor: 2.260

Review 5.  Microbiome in Rheumatoid Arthritis and Celiac Disease: A Friend or Foe.

Authors:  Kawther Elsouri; Vania Arboleda; Samantha Heiser; Marc M Kesselman; Michelle Demory Beckler
Journal:  Cureus       Date:  2021-06-09

Review 6.  Gluten Degrading Enzymes for Treatment of Celiac Disease.

Authors:  Guoxian Wei; Eva J Helmerhorst; Ghassan Darwish; Gabriel Blumenkranz; Detlef Schuppan
Journal:  Nutrients       Date:  2020-07-15       Impact factor: 5.717

7.  Oropharyngeal microbiome evaluation highlights Neisseria abundance in active celiac patients.

Authors:  Laura Iaffaldano; Ilaria Granata; Chiara Pagliuca; Maria Valeria Esposito; Giorgio Casaburi; Giuliana Salerno; Roberta Colicchio; Marina Piccirillo; Carolina Ciacci; Giovanna Del Vecchio Blanco; Mario Rosario Guarracino; Paola Salvatore; Francesco Salvatore; Valeria D'Argenio; Lucia Sacchetti
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

Review 8.  Role of the gut microbiota in the pathogenesis of coeliac disease and potential therapeutic implications.

Authors:  Anthony K Akobeng; Parul Singh; Manoj Kumar; Souhaila Al Khodor
Journal:  Eur J Nutr       Date:  2020-07-10       Impact factor: 5.614

9.  Microbiome of root vegetables-a source of gluten-degrading bacteria.

Authors:  Viia Kõiv; Kaarel Adamberg; Signe Adamberg; Ingrid Sumeri; Sergo Kasvandik; Veljo Kisand; Ülo Maiväli; Tanel Tenson
Journal:  Appl Microbiol Biotechnol       Date:  2020-09-02       Impact factor: 4.813

Review 10.  Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics.

Authors:  Katherine L Olshan; Maureen M Leonard; Gloria Serena; Ali R Zomorrodi; Alessio Fasano
Journal:  Expert Rev Clin Immunol       Date:  2020-12-27       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.